Symbol Name ID |
Agpat2
1-acylglycerol-3-phosphate O-acyltransferase 2 MGI:1914762 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Hypertriglyceridemia |
Elevated circulating hepatic transaminase concentration |
Diabetes mellitus |
Insulin-resistant diabetes mellitus at puberty |
Hyperinsulinemia |
Hepatic steatosis |
Decreased serum leptin |
Disease(s) Associated with AGPAT2 | |||||||
congenital generalized lipodystrophy type 1 |
Mouse Phenotypes | homeostasis/metabolism phenotype |
increased circulating glucose level |
hyperglycemia |
increased circulating insulin level |
decreased circulating leptin level |
increased circulating cholesterol level |
decreased circulating free fatty acids level |
increased circulating triglyceride level |
decreased body temperature |
abnormal gas homeostasis |
increased carbon dioxide production |
increased oxygen consumption |
decreased respiratory quotient |
abnormal glucose homeostasis |
improved glucose tolerance |
insulin resistance |
abnormal lipid homeostasis |
abnormal fatty acids level |
abnormal phospholipid level |
increased liver triglyceride level |
|
Availability | Mouse Genotype | ||||||||||||||||||||
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex | |||||||||||||||||||||
Agpat2tm1Garg/Agpat2tm1Garg | * |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|